Licence Changes & Product Updates

NICE recommends further migraine prevention option

NICE recommends further migraine prevention option

23 November 2020, 5:43pm

Galcanezumab (Emgality) is the second calcitonin gene-related...

Diabetes drug approved to treat heart failure

Diabetes drug approved to treat heart failure

11 November 2020, 10:57am

Forxiga (dapagliflozin) is the first SGLT2 inhibitor...

New tablet treatment for eczema

New tablet treatment for eczema

28 October 2020, 5:13pm

Prescribers have a new oral treatment option for patients...

New warnings and restrictions for stimulant laxatives

New warnings and restrictions for stimulant laxatives

19 August 2020, 4:53pm

The MHRA has issued new safety warnings, revised recommended...

First SGLT2 inhibitor approved to treat diabetic kidney disease

First SGLT2 inhibitor approved to treat diabetic kidney disease

15 July 2020, 10:57am

Canagliflozin (Invokana) can now be prescribed to slow...

New contraindication for co-cyprindiol

New contraindication for co-cyprindiol

1 July 2020, 9:46am

Cyproterone-containing medicines are now contraindicated...

Uterine fibroid drug suspended over liver injury concerns

Uterine fibroid drug suspended over liver injury concerns

19 March 2020, 11:39am

Healthcare professionals have been asked to stop prescribing...

Beta blocker overdose warning

Beta blocker overdose warning

13 February 2020, 9:32am

The toxicity of a commonly prescribed beta blocker...

Three Insuman insulin presentations to be discontinued

Three Insuman insulin presentations to be discontinued

10 February 2020, 11:24am

The Insuman range is being rationalised owing to manufacturing...

Actinic keratosis treatment recalled due to growing skin cancer concerns

Actinic keratosis treatment recalled due to growing skin cancer concerns

27 January 2020, 1:46pm

Healthcare professionals have been advised to stop...

MIMS Clinics

Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.